TickerFacts.

Medicinova Inc (MNOV): Revenue

Annual figures by period end, from SEC filings.

$409.7K
Year ended 2025-12-31
$920.5K
Trailing 12 months to 2026-06-30
$4.04M2021-12-31: $4.04M2023-12-31: $1.00M2025-12-31: $409.7K$409.7K
2021-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$409.7Kn/a2026-03-10, From 2025-01-01
No annual figure between 2023-12-31 and 2025-12-31.
2023-12-31$1.00Mn/a2025-02-19, From 2023-01-01
No annual figure between 2021-12-31 and 2023-12-31.
2021-12-31$4.04Mn/a2023-03-28, From 2021-01-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Medicinova Inc (MNOV)2025-12-31$409.7Kn/a
Can-Fite BioPharma Ltd. (CANF)2025-12-31$405.0K-39.9%
America Great Health (AAGH)2025-06-30$391.7K+32.9%
Scienture Holdings, Inc. (SCNX)2025-12-31$431.6K+215.9%
Provectus Biopharmaceuticals, Inc. (PVCT)2025-12-31$336.1K-45.5%
Mereo BioPharma Group plc (MREO)2025-12-31$500.0Kn/a
Allarity Therapeutics, Inc. (ALLR)2025-12-31$320.0Kn/a
Vyome Holdings, Inc (HIND)2025-12-31$319.7K+24.4%
Lipella Pharmaceuticals Inc. (LIPO)2024-12-31$536.4K+19.3%

Compare MNOV, CANF, AAGH, SCNX side by side · Screen every company in Pharmaceutical Preparations ↗